Concerns and Treatment Satisfaction in Patients Being Treated with Azelaic Acid Foam for Rosacea
Williamson, T.; Cameron, J.; McLeod, K.; Turner, B.; Quillen, A.; LaRose, A.; Lott, J.; Gaiser, A.
Journal of Drugs in Dermatology Jdd 18(4): 381-386
2019
ISSN/ISBN: 1545-9616 PMID: 31013011 Document Number: 17767
Objective: To describe patient characteristics, concerns, side effects, treatment satisfaction, and quality of life (QoL) of rosacea patients currently being treated with monotherapy azelaic acid foam based on patient-reported data.
Document emailed within 1 workday
Related Documents
Hashim, P.W.; Chen, T.; Harper, J.C.; Kircik, L.H. 2018: The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Facial Acne Vulgaris Journal of Drugs in Dermatology: Jdd 17(6): 641-645Hoffman, L.K.; Del Rosso, J.Q.; Kircik, L.H. 2017: The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris Journal of Drugs in Dermatology: Jdd 16(6): 534-538
Johnson, S.Marchese.; LeVine, P. 2011: Self-reported treatment impressions and satisfaction of papulopustular rosacea patients treated with doxycycline, USP, 40 mg capsules Journal of Drugs in Dermatology: Jdd 10(12): 1376-1381
Wolf, J.E.; Kerrouche, N.; Arsonnaud, S. 2006: Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea Cutis 77(4 Suppl): 3-11
Thiboutot, D.M.; Fleischer, A.B.; Del Rosso, J.Q.; Rich, P. 2009: A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy Journal of Drugs in Dermatology: Jdd 8(7): 639-648
Thiboutot, D.M.; Fleischer, A.B.; Del Rosso, J.Q.; Graupe, K. 2008: Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea Journal of Drugs in Dermatology: Jdd 7(6): 541-546
Jackson, J.M.; Kircik, L.H.; Lorenz, D.J. 2013: Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea Journal of Drugs in Dermatology: Jdd 12(3): 292-298
Trumbore, M.W.; Goldstein, J.A.; Gurge, R.M. 2009: Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam Journal of Drugs in Dermatology: Jdd 8(3): 299-304
Thiboutot, D. 2008: Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris Journal of Drugs in Dermatology: Jdd 7(1): 13-16
Bhatia, N.; Kircik, L. 2018: Clobetasol Emulsion Foam and Calcipotriene 0.005% Foam Combination Therapy for the Maintenance of Treatment Response in Patients with Moderate Plaque Psoriasis Journal of Drugs in Dermatology: Jdd 17(3): 342-346
Frankel, A.; Sohn, A.; Patel, R.V.; Lebwohl, M. 2011: Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis Journal of Drugs in Dermatology: Jdd 10(6): 666-672
Miklósy, L.; Dittrói, K. 1977: Complex chemical burns caused by phthalic acid anhydride treated by Panthenol spray foam floatation Orvosi Hetilap 118(30): 1787
Baldwin, H.E. 2010: A community-based study of the effectiveness of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea Cutis 86(5 Suppl): 26-36
Michel, J-L.; Cabibel, F. 2003: Frequency, severity and treatment of ocular rosacea during cutaneous rosacea Annales de Dermatologie et de Venereologie 130(1 Pt 1): 20-24
Feldman, S.R.; Mills, M.; Brundage, T.; Eastman, W.J. 2013: A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp Journal of Drugs in Dermatology: Jdd 12(3): 300-306
Kircik, L. 2011: Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis Journal of Drugs in Dermatology: Jdd 10(3): 270-273
Kircik, L.H.; Eastman, W.J.; Gwazdauskas, J. 2013: A randomized, double-blind phase 4 study of the efficacy and safety of ethanol-free clobetasol propionate foam, 0.05%, vs vehicle foam in the treatment of chronic hand dermatitis Journal of Drugs in Dermatology: Jdd 12(3): 328-334
Woolery-Lloyd, H.C.; Keri, J.; Doig, S. 2013: Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color Journal of Drugs in Dermatology: Jdd 12(4): 434-437
Iraji, F.; Faghihi, G.; Siadat, A.H.; Enshaieh, S.; Shahmoradi, Z.; Joia, A.; Soleimani, F. 2010: Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial Journal of Drugs in Dermatology: Jdd 9(8): 964-968
Ziel, K.; Yelverton, C.B.; Balkrishnan, R.; Feldman, S.R. 2005: Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin Journal of Drugs in Dermatology: Jdd 4(6): 727-731